UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 522

Sortiert nach

1409PAssociation of efficacy and immune-related adverse events (irAEs) in patients with NSCLC receiving immune-checkpoint inhibitors (ICIs)

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

1562PDMagnitude of clinical benefit of cancer drugs approved based on single-arm trials (SAT) by the US Food and Drug Administration (FDA)

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

1563PDMagnitude of clinical benefit in trials supporting US Food and Drug Administration (FDA) accelerated approval (AA) and European Medicines Agency (EMA) conditional marketing authorisation (CMA) and subsequent trials supporting conversion to full approval

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

1564PDMagnitude of clinical benefit of trials supporting US Food and Drug Administration (FDA) approval of breakthrough and non-breakthrough drugs

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

1583O Clinical benefit of cancer drugs approved in Switzerland during the last decade

Annals of oncology, 2020-09, Vol.31, p.S961-S961

2020

Volltextzugriff (PDF)

1585MO Factors associated with change in overall survival and quality of life between time of approval and post-marketing among anti-cancer therapies

Annals of oncology, 2020-09, Vol.31, p.S961-S962

2020

Volltextzugriff (PDF)

1627O - Change in magnitude of clinical benefit, overall survival (OS) and quality of life (QoL) between time of approval and post-marketing among cancer drugs approved by the US Food and Drug Administration (FDA) 2006-2015

Annals of oncology, 2019-10, Vol.30, p.v671-v671

2019

Volltextzugriff (PDF)

1627OChange in magnitude of clinical benefit, overall survival (OS) and quality of life (QoL) between time of approval and post-marketing among cancer drugs approved by the US Food and Drug Administration (FDA) 2006-2015

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

1638P Are all leiomyosarcomas created equal? Clinical characteristics and experience of a single reference centre

Annals of oncology, 2020-09, Vol.31, p.S981-S981

2020

Volltextzugriff (PDF)

1704P Clinical benefit of cancer drugs approved by the US food and drug administration based on appropriateness of control arm and its change over time

Annals of oncology, 2023-10, Vol.34, p.S931-S931

2023

Volltextzugriff (PDF)

1706P Time to full approval of novel anticancer medicines granted accelerated approval and implications for reform of the accelerated approval pathway

Annals of oncology, 2023-10, Vol.34, p.S931-S931

2023

Volltextzugriff (PDF)

Di(2-pyridyl)methylamine–palladium dichloride complex covalently anchored to a styrene-maleic anhydride co-polymer as recoverable catalyst for C–C cross-coupling reactions in water

Tetrahedron, 2005-12, Vol.61 (51), p.12168-12176

2005

Volltextzugriff (PDF)

2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

Annals of the rheumatic diseases, 2020-01, Vol.79 (1), p.39

2020

Volltextzugriff (PDF)

252P Impact of informative censoring on the interpretation of progression-free survival (PFS) estimates in phase III randomized trials (RCT) in metastatic breast cancer (MBC)

ESMO open, 2024-05, Vol.9, p.103273, Article 103273

2024

Volltextzugriff (PDF)

388PImpaired survival in resected glioblastoma multiforme patients treated with early chemoradiation

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

AB0547 Bone mineral density (bmd) assessment in patients with symptoms suggestive of spondyloarthritis: an accurate tool for diagnosis

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A956-A956

2013

Volltextzugriff (PDF)

AB0692 Parameters Associated with Severe Axial Structural Involvement: Data from The Bamboo Spine Cohort on 133 Spondyloarthritis Patients

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.1141-1141

2016

Volltextzugriff (PDF)

AB0769 Does the Inclusion of Extra-Articular Manifestations Improve Validity of the Self-Administered Comorbidity Questionnaire Modified for Spondyloartritis (SPA-SCQ)? Results From Asas-Comospa

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1156-1156

2015

Volltextzugriff (PDF)

AB0791 Why Do Patients with Axial Spondyloarthritis (AXSPA) Perform Little Aerobic Exercise? A Study of Perceived Barriers and Benefits in 153 Axspa Patients

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1164-1164

2015

Volltextzugriff (PDF)

Abdominal ultrasound in ovarian hyperstimulation syndrome

Revista española de anestesiología y reanimación, 2012-04, Vol.59 (4), p.231-231

2012

Volltextzugriff (PDF)

Absence Ochratoxin A in soy sauce

International journal of food microbiology, 2004-12, Vol.97 (2), p.221-225

2004

Volltextzugriff (PDF)

Accelerated Solvent Extraction of Ochratoxin A from Rice Samples

Journal of agricultural and food chemistry, 2005-11, Vol.53 (24), p.9348-9351

2005

Volltextzugriff (PDF)

Accord de 357 professionnels de santé avec les recommandations des Rencontres d’Experts 2019 sur l’adhésion médicamenteuse

Revue du rhumatisme (Ed. française : 1993), 2021-03, Vol.88 (2), p.159-161

2021

Volltextzugriff (PDF)

Accord patient–médecin sur le BASDAI chez des patients atteints de spondyloarthrite axiale

Revue du rhumatisme (Ed. française : 1993), 2018-12, Vol.85 (6), p.593-594

2018

Volltextzugriff (PDF)

L’activité de la maladie et le syndrome douloureux chronique sont les éléments clés de la santé globale dans la spondyloarthrite axiale : une analyse de 4 bases de données et 6064 patients

Revue du rhumatisme (Ed. française : 1993), 2023-12, Vol.90, p.A233

2023

Volltextzugriff (PDF)

1 – 25 von 522

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(401)
Mit Volltextzugriff
(473)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(246)
Life Sciences & Biomedicine
(220)
Humans
(176)
Female
(96)
Biological And Medical Sciences
(94)
Male
(93)
Adult
(74)
Middle Aged
(61)
Fundamental And Applied Biological Sciences. Psychology
(55)
Medical Sciences
(53)
Chemistry
(52)
Physical Sciences
(48)
Infectious Diseases
(42)
Aged
(37)
Food Industries
(35)
Chemistry, Analytical
(32)
Food Science & Technology
(32)
Microbiology
(32)
Human Immunodeficiency Virus
(30)
Hiv Infections - Drug Therapy
(29)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

1409PAssociation of efficacy and immune-related adverse events (irAEs) in patients with NSCLC receiving immune-checkpoint inhibitors (ICIs)

1562PDMagnitude of clinical benefit of cancer drugs approved based on single-arm trials (SAT) by the US Food and Drug Administration (FDA)

1563PDMagnitude of clinical benefit in trials supporting US Food and Drug Administration (FDA) accelerated approval (AA) and European Medicines Agency (EMA) conditional marketing authorisation (CMA) and subsequent trials supporting conversion to full approval

1564PDMagnitude of clinical benefit of trials supporting US Food and Drug Administration (FDA) approval of breakthrough and non-breakthrough drugs

1583O Clinical benefit of cancer drugs approved in Switzerland during the last decade

1585MO Factors associated with change in overall survival and quality of life between time of approval and post-marketing among anti-cancer therapies

1627O - Change in magnitude of clinical benefit, overall survival (OS) and quality of life (QoL) between time of approval and post-marketing among cancer drugs approved by the US Food and Drug Administration (FDA) 2006-2015

1627OChange in magnitude of clinical benefit, overall survival (OS) and quality of life (QoL) between time of approval and post-marketing among cancer drugs approved by the US Food and Drug Administration (FDA) 2006-2015

1638P Are all leiomyosarcomas created equal? Clinical characteristics and experience of a single reference centre

1704P Clinical benefit of cancer drugs approved by the US food and drug administration based on appropriateness of control arm and its change over time

1706P Time to full approval of novel anticancer medicines granted accelerated approval and implications for reform of the accelerated approval pathway

Di(2-pyridyl)methylamine–palladium dichloride complex covalently anchored to a styrene-maleic anhydride co-polymer as recoverable catalyst for C–C cross-coupling reactions in water

2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

252P Impact of informative censoring on the interpretation of progression-free survival (PFS) estimates in phase III randomized trials (RCT) in metastatic breast cancer (MBC)

388PImpaired survival in resected glioblastoma multiforme patients treated with early chemoradiation

AB0547 Bone mineral density (bmd) assessment in patients with symptoms suggestive of spondyloarthritis: an accurate tool for diagnosis

AB0692 Parameters Associated with Severe Axial Structural Involvement: Data from The Bamboo Spine Cohort on 133 Spondyloarthritis Patients

AB0769 Does the Inclusion of Extra-Articular Manifestations Improve Validity of the Self-Administered Comorbidity Questionnaire Modified for Spondyloartritis (SPA-SCQ)? Results From Asas-Comospa

AB0791 Why Do Patients with Axial Spondyloarthritis (AXSPA) Perform Little Aerobic Exercise? A Study of Perceived Barriers and Benefits in 153 Axspa Patients

Abdominal ultrasound in ovarian hyperstimulation syndrome

Absence Ochratoxin A in soy sauce

Accelerated Solvent Extraction of Ochratoxin A from Rice Samples

Accord de 357 professionnels de santé avec les recommandations des Rencontres d’Experts 2019 sur l’adhésion médicamenteuse

Accord patient–médecin sur le BASDAI chez des patients atteints de spondyloarthrite axiale

L’activité de la maladie et le syndrome douloureux chronique sont les éléments clés de la santé globale dans la spondyloarthrite axiale : une analyse de 4 bases de données et 6064 patients

Suchergebnisse filtern